EFX Labs will be conducting accelerated cannabis research with our partners.
We are sponsoring a Health Canada submission of a Phase II/III Clinical Trial measuring cannabis as a viable post-operative treatment. The cannabis oil being used for research is formulated by Aphria specific for the clinical/ethics study submission using supercritical extracted cannabis diluted in MCT oil. The Ethics application is estimated to be submitted early 2019 and will not obtain full Health Canada review until mid-2019. We are focused on using the ultimate in extractions, formulations and delivery for maximum positive effect.